{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:57:40Z","timestamp":1769075860604,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00520-020-05778-2","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T14:02:44Z","timestamp":1600524164000},"page":"2537-2547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancer"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-2599","authenticated-orcid":false,"given":"Sarah Nicole","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Berthelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonn","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"DeVries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"LaPointe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minette","family":"Lagman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,19]]},"reference":[{"key":"5778_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejca.2015.12.025","volume":"56","author":"RL Mercieca-Bebber","year":"2016","unstructured":"Mercieca-Bebber RL, Perreca A, King M, Macann A, Whale K, Soldati S, Jacobs M, Efficace F (2016) Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: a systematic review of completeness of reporting and impact on interpretation. Eur J Cancer 56:144\u2013161","journal-title":"Eur J Cancer"},{"issue":"4","key":"5778_CR2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ijrobp.2012.08.030","volume":"85","author":"KU Hunter","year":"2013","unstructured":"Hunter KU, Schipper M, Feng FY, Lyden T, Haxer M, Murdoch-Kinch CA, Cornwall B, Lee CS, Chepeha DB, Eisbruch A (2013) Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes. Int J Radiat Oncol Biol Phys 85(4):935\u2013940","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5778_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jamaoto.2013.5988","volume":"140","author":"AM Chen","year":"2014","unstructured":"Chen AM, Daly ME, Farwell G, Vazquez E, Courquin J, Lau DH, Purdy JA (2014) Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy. JAMA Otolaryngol Head Neck Surg 140(2):129\u2013133","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"5778_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11864-018-0578-1","volume":"19","author":"A Silveira","year":"2018","unstructured":"Silveira A, Monteiro E, Sequeira T (2018) Head and neck cancer: improving patient-reported outcome measures for clinical practice. Curr Treat Options Oncol 19:11","journal-title":"Curr Treat Options Oncol"},{"key":"5778_CR5","doi-asserted-by":"publisher","unstructured":"Franco P, Martini S, Di Muzio J, et al. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.\u00a0Med Oncol 2017;34(5):81. https:\/\/doi.org\/10.1007\/s12032-017-0950-1","DOI":"10.1007\/s12032-017-0950-1"},{"key":"5778_CR6","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1200\/JCO.2015.61.4115","volume":"33","author":"J Ringash","year":"2015","unstructured":"Ringash J (2015) Survivorship and quality of life in head and neck cancer. Am Soc Clin Oncol 33:3322\u20133327","journal-title":"Am Soc Clin Oncol"},{"key":"5778_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.radonc.2019.04.030","volume":"137","author":"JR Wilkie","year":"2019","unstructured":"Wilkie JR, Mierzwa ML, Yao J, Eisbruch A, Feng M, Weyburne G, Chen X, Holevinski L, Mayo CS (2019) Big data analysis of associations between patient reported outcomes, observer reported toxicities, and overall quality of life in head and neck cancer patients treated with radiation therapy. Radiother Oncol 137:167\u2013174","journal-title":"Radiother Oncol"},{"issue":"6","key":"5778_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/jamaoto.2016.0656","volume":"142","author":"AD Falchook","year":"2016","unstructured":"Falchook AD, Green R, Knowles ME, Amdur RJ, Mendenhall W, Hayes DN, Grilley-Olson JE, Weiss J, Reeve BB, Mitchell SA, Basch EM, Chera BS (2016) Comparison of patient- and practitioner-reported toxic effects associated with chemoradiotherapy for head and neck cancer. JAMA Otolaryngol Head Neck Surg 142(6):517\u2013523","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"5778_CR9","doi-asserted-by":"publisher","unstructured":"Xiao C, Polomano R, Bruner DW (2013) Comparison between patient-reported and clinician-observed symptoms in oncology.\u00a0Cancer Nurs 36(6):E1\u2013E16. https:\/\/doi.org\/10.1097\/NCC.0b013e318269040f","DOI":"10.1097\/NCC.0b013e318269040f"},{"key":"5778_CR10","doi-asserted-by":"crossref","unstructured":"Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D (2017) Overall survival results of a trial assessing patient-reported uutcomes for symptom monitoring during routine cancer treatment. JAMA 318(2):197","DOI":"10.1001\/jama.2017.7156"},{"issue":"3","key":"5778_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/bjc.2013.725","volume":"110","author":"CM Booth","year":"2014","unstructured":"Booth CM, Tannock IF (2014) Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer 110(3):551\u2013555","journal-title":"Br J Cancer"},{"issue":"13","key":"5778_CR12","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1002\/cncr.28672","volume":"120","author":"DI Rosenthal","year":"2014","unstructured":"Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB (2014) Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer 120(13):1975\u20131984","journal-title":"Cancer"},{"issue":"12","key":"5778_CR13","doi-asserted-by":"publisher","first-page":"E437","DOI":"10.1002\/lary.27801","volume":"129","author":"ML Nilsen","year":"2019","unstructured":"Nilsen ML, Mady LJ, Hodges J, Wasserman-Wincko T, Johnson JT (2019) Burden of treatment: reported outcomes in a head and neck cancer survivorship clinic. Laryngoscope 129(12):E437\u2013E444","journal-title":"Laryngoscope"},{"issue":"4","key":"5778_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.otohns.2006.12.006","volume":"136","author":"A Pusic","year":"2007","unstructured":"Pusic A, Liu JC, Chen CM, Cano S, Davidge K, Klassen A, Branski R, Patel S, Kraus D, Cordeiro PG (2007) A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngol Head Neck Surg 136(4):525\u2013535","journal-title":"Otolaryngol Head Neck Surg"},{"key":"5778_CR15","doi-asserted-by":"publisher","unstructured":"Allen-Ayodabo CO, Eskander A, Davis LE, et al. (2019) Symptom burden among head and neck cancer patients in the first year after diagnosis: association with primary treatment modality.\u00a0Oral Oncol 99:104434. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.09.026","DOI":"10.1016\/j.oraloncology.2019.09.026"},{"issue":"1","key":"5778_CR16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/hed.21143","volume":"32","author":"BA Murphy","year":"2010","unstructured":"Murphy BA, Dietrich MS, Wells N, Dwyer K, Ridner SH, Silver HJ, Gilbert J, Chung CH, Cmelak A, Burkey B, Yarbrough WG, Sinard R, Netterville J (2010) Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation. Head Neck 32(1):26\u201337","journal-title":"Head Neck"},{"key":"5778_CR17","doi-asserted-by":"crossref","unstructured":"Cooperstein E, Gilbert J, Epstein JB, Dietrich MS, Bond SM, Ridner SH, Wells N, Cmelak A, Murphy BA (2012) Vanderbilt head and neck symptom survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health. Head Neck 34(6):797\u2013804","DOI":"10.1002\/hed.21816"},{"key":"5778_CR18","doi-asserted-by":"crossref","unstructured":"Niska JR, Halyard MY, Tan AD, Atherton PJ, Patel SH, Sloan JA (2017) Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer. Qual Life Res 26(7):1721\u20131731","DOI":"10.1007\/s11136-017-1528-2"},{"key":"5778_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.oraloncology.2018.10.006","volume":"86","author":"E Orlandi","year":"2018","unstructured":"Orlandi E, Iacovelli NA, Rancati T, Cicchetti A, Bossi P, Pignoli E, Bergamini C, Licitra L, Fallai C, Valdagni R, Cavallo A (2018) Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients. Oral Oncol 86:266\u2013272","journal-title":"Oral Oncol"},{"issue":"1","key":"5778_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijom.2019.06.012","volume":"49","author":"A Musha","year":"2020","unstructured":"Musha A, Fukata K, Saitoh JI, Shirai K, Abe T, Mizukami T, Kawashima M, Yokoo S, Chikamatsu K, Ohno T, Nakano T (2020) Tongue surface model can predict radiation tongue mucositis due to intensity-modulated radiation therapy for head and neck cancer. Int J Oral and Maxillofac Surg 49(1):44\u201350","journal-title":"Int J Oral and Maxillofac Surg"},{"key":"5778_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/PROM.S153919","volume":"9","author":"MS Peach","year":"2018","unstructured":"Peach MS, Trifiletti D, Vachani C, Arnold-Korzeniowski K, Bach C, Hampshire M, Metz J, Hill-Kayser C (2018) Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity. Patient Relat Outcome Meas 9:245\u2013252","journal-title":"Patient Relat Outcome Meas"},{"key":"5778_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.oraloncology.2019.06.008","volume":"95","author":"JL Barbosa da Silva","year":"2019","unstructured":"Barbosa da Silva JL, Doty RL, Miyazaki JVMK, Borges R, de Rezende Pinna F, Voegels RL, Fornazieri MA (2019) Fornazieri, Gustatory disturbances occur in patients with head and neck cancer who undergo radiotherapy not directed to the oral cavity. Oral Oncol 95:115\u2013119","journal-title":"Oral Oncol"},{"issue":"2","key":"5778_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijrobp.2016.05.011","volume":"96","author":"E Sapir","year":"2016","unstructured":"Sapir E, Tao Y, Feng F, Samuels S, El Naqa I, Murdoch-Kinch CA, Feng M, Schipper M, Eisbruch A (2016) Predictors of dysgeusia in patients with oropharyngeal cancer treated with chemotherapy and intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 96(2):354\u2013361","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5778_CR24","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.2196\/cancer.7202","volume":"3","author":"J Norquist","year":"2017","unstructured":"Norquist J, Chirovsky D, Munshi T, Tolley C (2017) Panter and Gater Adam, Assessing the comparability of paper and electronic versions of the EORTC QOL module for head and neck cancer: a qualitative study. JMIR Cancer 3(1):e7","journal-title":"JMIR Cancer"},{"issue":"4","key":"5778_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ijrobp.2016.12.033","volume":"97","author":"J Ringash","year":"2017","unstructured":"Ringash J (2017) Quality of life in head and neck cancer: where we are, and where we are going. Int J Radiat Oncol Biol Phys 97(4):662\u2013666","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"5778_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/0284186X.2018.1563713","volume":"58","author":"C Holl\u00e4nder-Mieritz","year":"2019","unstructured":"Holl\u00e4nder-Mieritz C, Johansen J, Johansen C, Vogelius IR, Kristensen CA, Pappot H (2019) Comparing the patients\u2019 subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires. Acta Oncol 58(5):603\u2013609","journal-title":"Acta Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05778-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05778-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05778-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:34:46Z","timestamp":1723613686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05778-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,19]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5778"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05778-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,19]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SH, ET, JW, KD, VL, AB and ML report no disclosures. RO has received grants from Varian Medical Systems related to this work. EB has received grants and personal fees from Genzyme and Eisai outside the submitted work. CH reports grants and personal fees from Astra Zeneca, personal fees from Boehringer Ingelheim, personal fees from BMS, personal fees from Roche, personal fees from Lilly, personal fees from Eisai personal fees from Merck and personal fees from Bayer outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved by institutional REB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}